Raymond James & Associates’s VEON VEON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-430
Closed -$5.27K 4087
2022
Q4
$5.27K Hold
430
﹤0.01% 3879
2022
Q3
$3K Hold
430
﹤0.01% 3910
2022
Q2
$5K Buy
+430
New +$5.74K ﹤0.01% 3975
2020
Q3
Sell
-557
Closed -$25K 3699
2020
Q2
$25K Sell
557
-55
-9% -$2.21K ﹤0.01% 3429
2020
Q1
$23K Buy
+612
New +$33.7K ﹤0.01% 3389

Other funds holding VEON

Raymond James & Associates's VEON Position: Q1 2023 in Review

Raymond James & Associates sold out of VEON (VEON) in Q1 2023, closing a stake of 430 shares — an estimated $5.27K sold.

Raymond James & Associates first reported a position in VEON in Q1 2020 and held it in 5 quarters. The position peaked at $25K in Q2 2020. 41 funds tracked by Wall St. Rank hold VEON as of Q1 2023.

  • Raymond James & Associates reported no remaining VEON position as of Q1 2023 after selling out during the quarter.
  • Raymond James & Associates sold 430 VEON shares in Q1 2023, an estimated $5.27K.
  • Raymond James & Associates first reported a position in VEON in Q1 2020 and held it in 5 quarters.
  • Raymond James & Associates's VEON position peaked at $25K in Q2 2020.
  • 41 funds tracked by Wall St. Rank held VEON as of Q1 2023.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.